Is PIP a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

779 people get PIP articles and Market Currents by email alert.

Get email alerts on PIP »

HEADLINES:

Biodefense: Live By Government Contracts, Die By Government Contracts
Tal Ben-Ami • Sun, May 12 • 1 Comment
PharmAthene Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8
PharmAthene Reports First Quarter 2013 Financial And Operational Results

PR Newswire (May 8, 2013)
PharmAthene To Host First Quarter 2013 Conference Call And Webcast On Wednesday, May 8, 2013

PR Newswire (May 6, 2013)
New Data Show PharmAthene's Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents

PR Newswire (Apr 17, 2013)
Stocks With Upcoming Legal Catalysts
Alexander Maxwell • Wed, Mar 27 • 27 Comments
PharmAthene Management Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Mar 13 • 1 Comment
PharmAthene Reports Year-End 2012 Financial And Operational Results

PR Newswire (Mar 13, 2013)
PharmAthene To Host Year-End 2012 Conference Call And Webcast On Wednesday, March 13, 2013

PR Newswire (Mar 12, 2013)
A Quick Look At 8 Biotechs Ready To Gain Momentum
Craig Keolanui • Mon, Mar 11 • 10 Comments
5 Medical Stock Losers From Last Week With High Short Ratios
Heisenberg Principle • Mon, Feb 11
PharmAthene To Present At The Noble Financial 9th Annual Equity Conference On Tuesday, January 22, 2013

PR Newswire (Jan 17, 2013)
PharmAthene Secures Exclusive License To PER.C6® Cell Line For Commercial Production Of Recombinant Bioscavenger

PR Newswire (Jan 14, 2013)
Good Chance For PharmAthene To Jump On Lucrative SIGA Litigation
PropThink • Fri, Jan 11 • 14 Comments
PharmAthene Announces Delaware Supreme Court Hears Oral Arguments In Its Litigation With SIGA Technologies

PR Newswire (Jan 10, 2013)
PharmAthene Management Discusses Q3 2012 Results - Earnings Call Transcript
Tue, Nov 6, 2012 • 1 Comment
PharmAthene Reports Third Quarter 2012 Financial Results

PR Newswire (Nov 6, 2012)
PharmAthene To Host Third Quarter 2012 Conference Call And Webcast On Tuesday, November 6, 2012

PR Newswire (Nov 5, 2012)
PharmAthene - All Is Not Lost Yet
Icarus Falling • Tue, Aug 14, 2012 • 24 Comments
PharmAthene Receives FDA Notification On SparVax™

PR Newswire (Aug 10, 2012)

To learn more about Seeking Alpha Pro, click here.

Good Chance For PharmAthene To Jump On Lucrative SIGA Litigation
PropThink • Fri, Jan 11 • 14 Comments
PharmAthene - All Is Not Lost Yet
Icarus Falling • Tue, Aug 14, 2012 • 24 Comments
A Great Year For PharmAthene
Roy Manning III • Tue, Apr 3, 2012 • 11 Comments
How PharmAthene's Lawsuit Win Could Mean Higher Stock Price
Scott Matusow • Thu, Feb 9, 2012 • 15 Comments
Siga's Setback Promises Gains For PharmAthene
VFC's Stock House • Sun, Sep 25, 2011 • 5 Comments
Why Pharmathene Could Go From $2 to $20
James Altucher • Fri, Oct 15, 2010 • 272 Comments

Biodefense: Live By Government Contracts, Die By Government Contracts
Tal Ben-Ami • Sun, May 12 • 1 Comment
Stocks With Upcoming Legal Catalysts
Alexander Maxwell • Wed, Mar 27 • 27 Comments
A Quick Look At 8 Biotechs Ready To Gain Momentum
Craig Keolanui • Mon, Mar 11 • 10 Comments
5 Medical Stock Losers From Last Week With High Short Ratios
Heisenberg Principle • Mon, Feb 11
Why Early Tuesday's Biotech Edge Is Bullish
James Stocklasar Thomas Jr. • Tue, Jul 17, 2012 • 17 Comments
2 Promising Small-Cap Pharma Plays Trading Under $5/Share
Matt Schilling • Mon, Jul 2, 2012 • 4 Comments
2 Pharma Plays Trading Under $2 For The Aggressive Investor
Matt Schilling • Sun, Jul 1, 2012 • 2 Comments
Weekly Stock Watch: Week Of June 25
VFC's Stock House • Mon, Jun 25, 2012 • 7 Comments
Weekly Stock Watch: Week Of June 4, 2012
VFC's Stock House • Mon, Jun 4, 2012
Stocks To Watch: Week Of May 7, 2012
VFC's Stock House • Mon, May 7, 2012 • 4 Comments
Weekly Stock Watch: April 30-May 4
VFC's Stock House • Sun, Apr 29, 2012 • 3 Comments
2 Large Cap And 2 Small Cap, Attention-Worthy Healthcare Stocks
Alex Shadunsky • Thu, Apr 19, 2012 • 7 Comments
Micro Cap Biotech Stocks Accumulated By The World's Largest Money Managers
GuruFundPicks • Wed, Mar 28, 2012 • 10 Comments
Stock Watch: SIGA Opens The Week With A Bang
VFC's Stock House • Tue, Mar 27, 2012
Siga Technologies: A $3 Stock With Huge Potential Upside
Bret Jensen • Mon, Mar 26, 2012 • 15 Comments
12 Highly Shorted Biotech Stocks Being Snapped Up By Insiders
Kapitall • Wed, Feb 15, 2012 • 1 Comment
Stocks To Watch Week Of Jan. 30
VFC's Stock House • Mon, Jan 30, 2012 • 4 Comments
Past Bouncers And Others Biotech Plays Ready To Move
MarketScanners • Thu, Jan 26, 2012 • 2 Comments
Stocks To Watch This Week
VFC's Stock House • Tue, Jan 10, 2012 • 5 Comments
Hedge Funds Love These 9 Rebounding Biotech Stocks
Kapitall • Sat, Jan 7, 2012 • 3 Comments

PharmAthene Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8
PharmAthene Management Discusses Q4 2012 Results - Earnings Call Transcript
Wed, Mar 13 • 1 Comment
PharmAthene Management Discusses Q3 2012 Results - Earnings Call Transcript
Tue, Nov 6, 2012 • 1 Comment

PharmAthene Reports First Quarter 2013 Financial And Operational Results

PR Newswire (May 8, 2013)
PharmAthene To Host First Quarter 2013 Conference Call And Webcast On Wednesday, May 8, 2013

PR Newswire (May 6, 2013)
New Data Show PharmAthene's Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents

PR Newswire (Apr 17, 2013)
PharmAthene Reports Year-End 2012 Financial And Operational Results

PR Newswire (Mar 13, 2013)
PharmAthene To Host Year-End 2012 Conference Call And Webcast On Wednesday, March 13, 2013

PR Newswire (Mar 12, 2013)
PharmAthene To Present At The Noble Financial 9th Annual Equity Conference On Tuesday, January 22, 2013

PR Newswire (Jan 17, 2013)
PharmAthene Secures Exclusive License To PER.C6® Cell Line For Commercial Production Of Recombinant Bioscavenger

PR Newswire (Jan 14, 2013)
PharmAthene Announces Delaware Supreme Court Hears Oral Arguments In Its Litigation With SIGA Technologies

PR Newswire (Jan 10, 2013)
PharmAthene Reports Third Quarter 2012 Financial Results

PR Newswire (Nov 6, 2012)
PharmAthene To Host Third Quarter 2012 Conference Call And Webcast On Tuesday, November 6, 2012

PR Newswire (Nov 5, 2012)
PharmAthene Receives FDA Notification On SparVax™

PR Newswire (Aug 10, 2012)
Department of Defense Exercises Options Under Contract for Nerve Agent Medical Countermeasure Program

PR Newswire (Aug 9, 2012)
PharmAthene Reports Second Quarter 2012 Financial Results

PR Newswire (Aug 7, 2012)
PharmAthene Announces Further Progress In Development Of Its SparVax™ Anthrax Vaccine Program

PR Newswire (Jun 14, 2012)
Delaware Chancery Court Issues Final Order And Judgment Upholding Its Favorable Ruling

PR Newswire (Jun 1, 2012)
PharmAthene Reports First Quarter 2012 Financial Results

PR Newswire (May 8, 2012)
PharmAthene To Host First Quarter 2012 Conference Call And Webcast On Tuesday, May 8, 2012

PR Newswire (May 2, 2012)
PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress

PR Newswire (Apr 12, 2012)
PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services

PR Newswire (Apr 3, 2012)
PharmAthene to Present at the Noble Financial Eighth Annual Equity Conference on Tuesday, January 17, 2012

PR Newswire (Jan 11, 2012)

PIP vs. ETF Alternatives

Company Description

Currently, there's no company description for PIP.

Sector: Healthcare

Industry: Biotechnology

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 8, 6:54 PM PharmAthene (PIP): Q1 EPS of -$0.04 beats by $0.01. Revenue of $6.48M beats by $0.98M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, January 10, 2:56 PM PharmAthene (PIP -7%) trades lower today after saying that it's awaiting a ruling after the Delaware Supreme Court heard oral arguments today related to on-going litigation against SIGA Technologies. SIGA appealed the final judgment in favor of PIP issued in May, in which PIP was awarded 50% of the net profits over a period of ten years from all sales of SIGA's smallpox antiviral therapeutic, Arestvyr. 1 Comment [Healthcare, On the Move]
Thursday, November 29, 2012, 12:45 PM Midday top 10 gainers: HGSH +48%. ACUR +46%. PBM +42%. BLOX +36%. OCZ +24%. THQI +23%. AXR +22%. CARV +21%. TELK +20%. OBCI +16%.
Midday top 10 Losers: LQDT -17%. VRML -13%. ATEA -12%. LZB -11%. HITK -10%. KSS -9%. LAS -9%. BKS -9%. ABCD -8%. PIP -7%. Comment! [On the Move]
Friday, August 10, 2012, 9:21 AM PharmAthene (PIP) sinking, down 15.1% premarket, as the FDA says it's put the firm's SparVax anthrax vaccine program on clinical hold. Details to come from the agency within 30 days, but no adverse effects have been reported as the trial hadn't yet begun. Comment! [Healthcare, On the Move, Breaking News]
Friday, August 10, 2012, 9:10 AM Premarket gainers: FIO +23%. JNS +18%. XIN +14%. BYI +7%. RIMM +6%.
Losers: UBNT -39%. RNDY -22%. SPRD -13%. PIP -11%. ATRS -6%. CPST -6%. DK -5%. Comment! [On the Move]
Friday, June 1, 2012, 10:36 AM PharmAthene (PIP +37%) soars today, after a U.S. court upheld a ruling awarding it a portion of profits received by Siga Technologies (SIGA -2.6%) from its smallpox antiviral drug, ST-246. The decision is just the latest development in what has turned out to be a long-running legal battle between the two companies. Comment! [On the Move, Healthcare]
Thursday, April 12, 2012, 2:30 PM Shares of PharmAthene (PIP +2.2%) head higher after sitting in negative territory most of the day off of word that the company will add a Phase II trial for SparVax after seeing high efficacy rates in initial human clinical trials on the anthrax vaccine. Comment! [Healthcare, On the Move]
Thursday, September 22, 2011, 6:20 PM Shares of SIGA Technologies (SIGA) were hammered -43% during the afternoon session today, after a Delaware court ruled in favor of PharmAthene (PIP) in a dispute involving SIGA's smallpox drug ST-246. Under the ruling, SIGA can keep the first $40M in net profit from sales of the drug, after which it must then hand over 50% of the net profits to PharmAthene for the next ten years. 2 Comments [Healthcare, On the Move]
Thursday, September 22, 2011, 2:17 PM PharmAthene (PIP +21%) soars after a Delaware court rules that Siga Technologies (SIGA -0.4%) must share profits from the sales of its smallpox drug that could total over $400M. 2 Comments [Healthcare, On the Move]
Tuesday, February 22, 2011, 5:10 PM Five potentially big gainers under $5, according to David Sterman: Biodel (BIOD), Pharmathene (PIP), Denny's (DENN), BSD Medical (BSDM), Hercules Offshore (HERO). 1 Comment
Monday, November 29, 2010, 9:00 AM Premarket gainers: AMRN +39%. VOLT +34%. IRE +22%. AMAG +21%. SGMO +10%. AIB +10%. PIP +6%. DNN +4%. URRE +4%.
Losers: DB -3%. ALU -3%. Comment!
Friday, October 29, 2010, 9:00 AM Premarket gainers: FMR +44%. VVUS +33%. MWW +20%. PWER +18%. TNAV +17%. CSTR +15%. AXTI +7%. ARNA +7%. MXIM +7%. OREX +6%. DECK +5%. NIPS +5%. AXL +4%. MSFT +4%.
Losers: NUVA -25%. EXAS -17%. GNW -11%. PIP -10%. FSLR -7%. IRE -7%. CRBC -7%. AIB -4%. Comment!
Monday, October 18, 2010, 9:00 AM Premarket gainers: KWK +15%. ISTA +15%. PPHM +9%. GNBT +8%. STX +6%. FBP +6%. STEM +6%. AGN +5%. PIP +5%.
Losers: PETS -13%. MMR -4%. Comment!

Frank Pigeon Sr.
I bought some PIP after reading a Seeking Alpha article. Can you do an article on PIP?
7/10/12
Reply (2)

• !Report Abuse
View all 2 replies
Roy Manning III: Did the last article on PIP. Legally they look stronger then when I wrote the article. Judge ruled in favor of PIP.
7/10/12
• !Report Abuse
Frank Pigeon Sr.: Thanks Roy. Be nice if Scott also had a favorable comment .
7/11/12
• !Report Abuse
Add a reply...

140 characters

jojo1942
jojo1942: $SIGA, $CPHD, $APKT, $MRK, $ABT, $KW, $NLY, $AA, $CSX, $ENTR,$ORCL,$TU, $CREE, $PIP, $PRU, $T, $VECO
3/7/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Skimiami
tic toc... What's up with the decision on PIP
9/20/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

BCox85
Whats up with the PIP decision, July's counting down...
7/26/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jamwil527
REMX,LYSCF,PIP,SIGA,KTOS,BAA,VHT,DBA,MOO,AVL,REE,MCP
6/22/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ohassett
PIP is spiraling down after news of direct share offering, could it be that the 20$ price target is no more,roll on july for court judgement
6/17/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Michael Bryant
PharmAthene (PIP) surged today on update of litigation with SIGA. http://yhoo.it/lHdsyh PIP would be a long term buy.
5/4/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

amscott8
Wind: I practiced alot. Its amazing how much $ u can control and gain per PIP.
4/1/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ohassett
PIP
2/25/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Alex B. Gray
Pharmathene PIP reported Q3 2010 revenues of $6.2M vs. $6.8M and a net loss of $4.3M vs. a net loss of $14M in 2009.
11/12/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Frank Pigeon Sr.
I bought some PIP after reading a Seeking Alpha article. Can you do an article on PIP?
7/10/12
Reply (2)

• !Report Abuse
View all 2 replies
Roy Manning III: Did the last article on PIP. Legally they look stronger then when I wrote the article. Judge ruled in favor of PIP.
7/10/12
• !Report Abuse
Frank Pigeon Sr.: Thanks Roy. Be nice if Scott also had a favorable comment .
7/11/12
• !Report Abuse
Add a reply...

140 characters

PIP PharmAthene, Inc

PIP

PharmAthene, Inc